Social media is an overwhelming part of our lives these days, but the Pew Research Center provided an in-depth look at just how much we rely on these platforms. In a 2025 report that looks at social m [...]
London-headquartered biotech startup Verdiva has emerged from stealth with a whopping $410mn for a new range of drugs aimed at tackling the obesity epidemic. It’s one of Europe’s largest-ever biot [...]
Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous w [...]
The software industry is racing to write code with artificial intelligence. It is struggling, badly, to make sure that code holds up once it ships.A survey of 200 senior site-reliability and DevOps le [...]
A rogue AI agent at Meta passed every identity check and still exposed sensitive data to unauthorized employees in March. Two weeks later, Mercor, a $10 billion AI startup, confirmed a supply-chain br [...]
Market researchers have embraced artificial intelligence at a staggering pace, with 98% of professionals now incorporating AI tools into their work and 72% using them daily or more frequently, accordi [...]
Enterprise companies are running AI agents ahead of the controls needed to manage them — and they deployed that way knowingly. That is the central finding from VentureBeat Research's June surve [...]
The use of GLP-1 meds — made popular by Ozempic (NVO) — among U.S. adults without diabetes more than tripled between 2018 and 2022, with annual spending surging from $1.6 billion to $5.8 billion.R [...]